A Randomized Comparison of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in Patients With Diabetes Mellitus

Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents

Ιoannis Iakovou · JAMA · 2005 · 3.1K citations · Full text

Endovascular Technique, Lumen-apposing Metal Stent, Surgery +19

Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects

Frans J.Th. Wackers, Lawrence H. Young, Silvio E. Inzucchi et al. · Diabetes Care · 2004 · 786 citations · Full text

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

John A. Ormiston, Patrick W. Serruys, Evelyn Regar et al. · The Lancet · 2008 · 714 citations

Percutaneous Coronary Intervention, Prospective Open-label Trial, Cardiovascular Disease +6

Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”

Pedro A. Lemos, Patrick W. Serruys, Ron T. van Domburg et al. · Circulation · 2003 · 543 citations · Full text

Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic Patients

Alban Dibra, Adnan Kastrati, Julinda Mehilli et al. · New England Journal of Medicine · 2005 · 489 citations